By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tecan has licensed molecular diagnostics intellectual property from Enigma Diagnostics that it will use to pursue development of an integrated diagnostics solution with another partner.

The Swiss lab technologies developer said today that the license covers IP that is used in Enigma's automated point-of-care molecular diagnostic system, the Enigma ML.

Financial terms of the license agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.